Reuters logo
Amgen to build biotech manufacturing plant in Singapore
January 16, 2013 / 9:01 PM / 5 years ago

Amgen to build biotech manufacturing plant in Singapore

* Plant would be Amgen’s first in Asia

* Investment planned at $200 million

Jan 16 (Reuters) - Amgen Inc, the world’s largest biotechnology company, announced on Wednesday plans to build a new manufacturing plant in Singapore.

Thousand Oaks, California-based Amgen said it plans to invest around $200 million in the project, which will initially focus on the production of antibody-based drugs.

Construction, in the Tuas Biomedical Park area of Singapore, is expected to begin in the next few months.

Reporting By Deena Beasley; Editing by Nick Zieminski

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below